| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/25/1996 | CA2210347A1 Nitrogen mustard prodrugs with novel lipophilic protecting groups, and processes for their production |
| 07/25/1996 | CA2210220A1 Compounds having effects on serotonin-related systems |
| 07/25/1996 | CA2210158A1 Monoclonal antibody 1a7 and use for the treatment of melanoma and small cell carcinoma |
| 07/25/1996 | CA2210079A1 4-aza-19-norandrostane derivatives |
| 07/25/1996 | CA2208856A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of cerebral degenerative disorders |
| 07/25/1996 | CA2208852A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for vasodilatory treatment or prophylaxis |
| 07/25/1996 | CA2208837A1 Use of 3,4-diphenyl chromans for the manufacture of a pharmaceutical composition for the treatment or prophylaxis of obesity |
| 07/24/1996 | WO1995003049A1 Methods of treating hiv with azaspiranes |
| 07/24/1996 | EP0722946A1 Process for the separation of 3-formyl-cephem derivatives |
| 07/24/1996 | EP0722944A1 2-9-Disubstituted Purin-6-ones |
| 07/24/1996 | EP0722943A1 9-Substituted 2-(2-n-alkoxyphenyl)-purin-6-ones |
| 07/24/1996 | EP0722942A1 Indole piperidine derivatives |
| 07/24/1996 | EP0722941A2 Compounds having effects on serotonin-related systems |
| 07/24/1996 | EP0722937A1 2,8-Disubstituted quinazolinone |
| 07/24/1996 | EP0722928A1 Bicyclic-aromatic compounds with strong biologic activity, pharmaceutical and cosmetic compositions containing them and uses thereof |
| 07/24/1996 | EP0722736A1 Topical composition containing an antagonist of substance P |
| 07/24/1996 | EP0722735A1 Parathyroid hypertensive factor |
| 07/24/1996 | EP0722734A1 NADH and NADPH therapeutic agents for nasal, sublingual, rectal and dermal administration |
| 07/24/1996 | EP0722733A1 Blood vessel thickening inhibitor and smooth muscle fiber migration inhibitor each containing 7-thiaprostaglandin e 1? compound as active ingredient |
| 07/24/1996 | EP0722732A1 Long-acting drug formulation containing pyrimidinedione derivatives |
| 07/24/1996 | EP0722730A1 Controlled release oxycodone compositions |
| 07/24/1996 | EP0722729A2 Aryl-substituted rhodanines for treating multiple sclerosis |
| 07/24/1996 | EP0722728A1 Benzofuran derivatives for inhibiting endometriosis |
| 07/24/1996 | EP0722727A1 Benzofuran derivatives for inhibiting uterine fibroid disease |
| 07/24/1996 | EP0722726A1 Benzofuran derivatives for inhibiting bone loss |
| 07/24/1996 | EP0722725A1 Vascular smooth muscle cell migration inhibitor |
| 07/24/1996 | EP0722724A1 Use of L-carnitine and its derivatives for reducing the toxic effects of cyclosporin-A and others immunosuppressants |
| 07/24/1996 | EP0722723A2 Phenol derivatives for treating multiple sclerosis |
| 07/24/1996 | EP0722722A1 Use of an antagonist of substance P for the treatment of cutaneous erythema of neurogenic origin |
| 07/24/1996 | EP0722720A1 Novel sugar coating composition for application to compressed medicinal tablets |
| 07/24/1996 | EP0722715A1 Cosmetic compositions containing lactate dehydrogenase inhibitors |
| 07/24/1996 | EP0722668A1 Improving the bulk density and drying economics of amino acids |
| 07/24/1996 | EP0722496A1 Pharmaceutical compositions and utilization thereof particularly for the treatment of neurodegenerative diseases |
| 07/24/1996 | EP0722454A1 Stable solvates of avermectin compounds |
| 07/24/1996 | EP0722453A1 Process and antiparasitic intermediates for doramectin |
| 07/24/1996 | EP0722451A1 Water-soluble retinoids |
| 07/24/1996 | EP0722448A1 O-aryl, o-alkyl, o-alkenyl and o-alkynyl-macrolides having immunosuppressive activity |
| 07/24/1996 | EP0722447A1 3-pyrrolidinylthio-carbapenem derivatives and their antimicrobal activity |
| 07/24/1996 | EP0722446A1 Distamycin a analogues as antitumour or antiviral agents |
| 07/24/1996 | EP0722442A1 Polyazacycloalkanes as dichelants |
| 07/24/1996 | EP0722440A1 Pyrimidinyl-glutamic acid derivatives |
| 07/24/1996 | EP0722439A1 Hiv protease inhibitors |
| 07/24/1996 | EP0722434A1 Nitric esters having anti-inflammatory and/or analgesic activity and process for their preparation |
| 07/24/1996 | EP0722431A1 Oxidized carotenoids, retinoids and related conjugated polyenes, and derived fractions and compounds useful as cell-differentiation inducers, cytostatic agents, and anti-tumor agents |
| 07/24/1996 | EP0722343A1 Treatment of tumors by genetic transformation of tumor cells with genes encoding negative selective markers and cytokines |
| 07/24/1996 | EP0722342A1 REGULATION OF bcl-2 GENE EXPRESSION |
| 07/24/1996 | EP0722327A1 Improvements relating to antibacterial compositions |
| 07/24/1996 | EP0722326A1 Highly sulfated maltooligosaccharides with heparin-like properties |
| 07/24/1996 | EP0722325A1 Composition for the treatment or prevention of herpes |
| 07/24/1996 | EP0722324A1 Pharmaceutical composition for immunoenhancement therapy |
| 07/24/1996 | EP0722323A1 Compositions containing prostaglandin e1 and/or troxerutine complexed with phosphatidylcholine for topical treatment of erectile impotence |
| 07/24/1996 | EP0722322A1 Compounds, compositions and treatment of allergies and inflammation therewith |
| 07/24/1996 | EP0722320A1 Use of nitric oxide-releasing compounds as hypoxic cell radiation sensitizers |
| 07/24/1996 | EP0722319A1 Anthracyclinone derivatives and their use in amyloidosis |
| 07/24/1996 | EP0722318A1 Chemically-defined non-polymeric valency platform molecules and conjugates thereof |
| 07/24/1996 | EP0722316A1 New emulsion formulation |
| 07/24/1996 | EP0722313A1 Viscoelastic compositions of fluorinated organic compounds |
| 07/24/1996 | EP0722312A1 Pharmaceutical composition to enhance tissue healing and regeneration and application kit comprising it |
| 07/24/1996 | EP0714300A4 Methods for modulating the human sexual response |
| 07/24/1996 | EP0647229B1 Diamine salts of clavulanic acid |
| 07/24/1996 | EP0630184B1 Effect of particle-size distribution of cellulose ethers on palatability of compositions |
| 07/24/1996 | EP0581954B1 Use of alpha-hydroxyketoalkyl derivatives as protective light filters |
| 07/24/1996 | CN1127527A Ribozyme gene therapy for HIV infection and Aids |
| 07/24/1996 | CN1127509A New peptide derivatives |
| 07/24/1996 | CN1127508A Fused benzazepine derivative and pharmaceutical composition containing the same |
| 07/24/1996 | CN1127502A Benzene derivative useful for ischemic diseases |
| 07/24/1996 | CN1127476A Plasma-like solution |
| 07/24/1996 | CN1127473A Combination of a progestational agent and a nitric oxide synthase substrate and/or donor for the treatment of preeclampsia and preterm labor |
| 07/24/1996 | CN1127472A Use of isovaleramide as a mild anxiolytic and mild sedative agent |
| 07/24/1996 | CN1127470A Once-a-day methoprolol oral dosage form |
| 07/24/1996 | CN1127301A A method for the resolution of a racemic mixture of nucleoside enantioners |
| 07/24/1996 | CN1127258A Novel a-nor-steroid-3-carboxylic acid derivatives |
| 07/24/1996 | CN1127257A Novel a-nor-steroid-3-carboxylic acid derivatives |
| 07/24/1996 | CN1127256A Novel a-nor-steroid-3-carboxylic acid derivatives |
| 07/24/1996 | CN1127254A New 1,3-dihydro-2H-pyrrolo|2,3-b¨pyridin-2-one and oxazolo|4,5-b¨pyridin-2(3H)-one compounds, a process for their preparation and pharmaceutical compositions containing them |
| 07/24/1996 | CN1127253A Synthesis of 3-(4-(2-aminoethoxy)-benzoyl)-2-aryl-6-hydroxybenzo(b) thiophenes 08/01/31 |
| 07/24/1996 | CN1127252A Branched-amino-sbustituted thiazoles, processes for their preparation and the pharmaceutical compositions which contain them |
| 07/24/1996 | CN1127250A 2,3-bridged 1,4-dihydropyridines, process for their preparation and their use as medicaments |
| 07/24/1996 | CN1127247A New o-arylmethyl-N-(thio)acylhydroxylamines, process for preparing them and pharmaceutical compositions containing them |
| 07/24/1996 | CN1127141A Molded articles and method of producing the same |
| 07/24/1996 | CN1127140A Cosmetic and skin-usefull composition containing water from hot spring, mineral water and agent against acne and oldening |
| 07/24/1996 | CN1127117A Application of googerotin used as antineoplastic medicine |
| 07/24/1996 | CN1127116A New composition and subcompositions of same: process for obtaining them and their molecular identification, and their anti-inflammatory, analgesic, antipruritic and local antipyretic therapeutic effec |
| 07/24/1996 | CN1127115A Use of 5-thia-1,4-diazabicyclo/4.2.0/octane-3,8-dioxo compounds in antitumor therapy |
| 07/24/1996 | CN1127114A Use of substituted 4-phenyl-6-amino-nicotinic acid derivatives as medicaments |
| 07/24/1996 | CN1127113A Angiotensin invertase inhibitor |
| 07/24/1996 | CN1127080A Folic acid intensified foodstuff |
| 07/24/1996 | CN1032360C Preparing process of tetrahydroberberine type quanternary ammonium compound |
| 07/23/1996 | US5539132 Cerulenin compounds for fatty acid synthesis inhibition |
| 07/23/1996 | US5539128 Compounds for inhibiting leukotriene receptors as antiasmatics, antiarthritics, skin disorders, antiulcer agents or cardiovascular disorders |
| 07/23/1996 | US5539126 Method for preparing homochiral maleimide intermediates, via silylation techniques |
| 07/23/1996 | US5539125 1-azabicyclo[3.3.0]octan derivative, salt thereof, process for the preparation of same and use thereof as hypermotility agents |
| 07/23/1996 | US5539122 Retroviral protease inhibiting compounds |
| 07/23/1996 | US5539120 Arylalkyl-amines having anticonvulsant and neuroprotective properties |
| 07/23/1996 | US5539116 Method and compositions for the synthesis of BCH-189 and related compounds |
| 07/23/1996 | US5539104 1,4 Diazocines as fibrinogen antagonists |
| 07/23/1996 | US5539098 5'-O-propionyl and 5'-O-butyryl esters of 2-amino-6-methoxy-9-(β-D-arabinofuranosyl)-9H-purine |
| 07/23/1996 | US5539082 Peptide nucleic acids |
| 07/23/1996 | US5539063 Polymer for making poly(ethylene glycol)-protein conjugates |
| 07/23/1996 | US5539001 Antimicrobial mixtures |